Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 99.83%925.39M | 178.36%580.37M | 351.08%273.1M | 64.69%756.65M | 19.31%463.08M | -36.00%208.5M | -76.05%60.54M | -58.42%459.43M | -54.40%388.12M | -45.34%325.79M |
| Operating income | 99.83%925.39M | 178.36%580.37M | 351.08%273.1M | 64.69%756.65M | 19.31%463.08M | -36.00%208.5M | -76.05%60.54M | -58.42%459.43M | -54.40%388.12M | -45.34%325.79M |
| Cost of sales | -13.30%-451.31M | -59.18%-303.32M | -115.78%-155.44M | -50.30%-569.73M | -30.23%-398.31M | 16.87%-190.55M | 52.00%-72.04M | 46.56%-379.07M | 44.60%-305.85M | 38.51%-229.23M |
| Operating expenses | -13.30%-451.31M | -59.18%-303.32M | -115.78%-155.44M | -50.30%-569.73M | -30.23%-398.31M | 16.87%-190.55M | 52.00%-72.04M | 46.56%-379.07M | 44.60%-305.85M | 38.51%-229.23M |
| Gross profit | 631.99%474.08M | 1,443.71%277.05M | 1,123.43%117.65M | 132.59%186.92M | -21.28%64.77M | -81.41%17.95M | -111.19%-11.5M | -79.68%80.37M | -72.48%82.27M | -56.74%96.56M |
| Administrative expenses | -29.62%-38.48M | -23.07%-24.3M | -34.48%-12.23M | -22.12%-47.57M | -2.80%-29.69M | -12.96%-19.75M | 5.09%-9.1M | 26.30%-38.95M | 16.19%-28.88M | 4.19%-17.48M |
| Research and development expenses | -115.68%-16.4M | -194.90%-8.55M | -318.81%-3.3M | -80.57%-15.72M | 3.01%-7.6M | 52.33%-2.9M | 83.05%-787K | 65.68%-8.71M | 58.10%-7.84M | 46.42%-6.08M |
| Special items of operating profit | -352.88%-865K | -351.41%-641K | -452.17%-508K | 41.13%-438K | 45.58%-191K | -77.50%-142K | -162.86%-92K | -55.32%-744K | 6.90%-351K | 72.97%-80K |
| Operating profit | 1,433.37%418.33M | 5,132.17%243.56M | 573.28%101.62M | 285.41%123.19M | -39.64%27.28M | -106.64%-4.84M | -124.28%-21.47M | -89.91%31.96M | -81.58%45.2M | -62.28%72.92M |
| Financing income | 79.84%9.36M | 77.30%6.73M | 47.31%1.81M | -27.34%5.11M | -11.78%5.2M | -35.69%3.79M | -41.50%1.23M | -22.65%7.03M | -33.52%5.9M | -12.39%5.9M |
| Financing cost | 16.30%-14.29M | 15.84%-9.58M | 11.67%-5M | 10.35%-22.39M | 11.62%-17.08M | 16.20%-11.39M | 15.55%-5.66M | 18.75%-24.97M | 18.24%-19.32M | 15.78%-13.59M |
| Special items of earning before tax | -222.53%-24.93M | 43.52%-5.68M | -426.59%-2.65M | 61.17%-12.69M | 74.21%-7.73M | 67.55%-10.05M | -115.23%-504K | -63.89%-32.69M | -15.47%-29.97M | -213.93%-30.98M |
| Earning before tax | 4,958.23%388.47M | 1,145.19%235.02M | 462.63%95.77M | 599.28%93.22M | 325.25%7.68M | -165.66%-22.49M | -130.30%-26.41M | -106.78%-18.67M | -99.12%1.81M | -80.32%34.25M |
| Tax | -309.91%-43.86M | -289.01%-32.7M | -2,804.70%-9.79M | -549.65%-27.92M | -47.31%-10.7M | 5.82%-8.41M | 104.26%362K | 91.38%-4.3M | 73.86%-7.26M | 56.52%-8.93M |
| After-tax profit from continuing operations | 11,514.91%344.62M | 754.93%202.32M | 430.08%85.98M | 384.29%65.3M | 44.68%-3.02M | -222.00%-30.89M | -133.12%-26.05M | -110.19%-22.97M | -103.09%-5.46M | -83.51%25.32M |
| Earning after tax | 11,514.91%344.62M | 754.93%202.32M | 430.08%85.98M | 384.29%65.3M | 44.68%-3.02M | -222.00%-30.89M | -133.12%-26.05M | -110.19%-22.97M | -103.09%-5.46M | -83.51%25.32M |
| Minority profit | 108.03%3.19M | 159.34%2.03M | 284.86%966K | 1.38%2.57M | -28.31%1.53M | -36.78%782K | -71.48%251K | -4.78%2.53M | 63.88%2.14M | 12.05%1.24M |
| Profit attributable to shareholders | 7,602.29%341.43M | 732.36%200.29M | 423.26%85.01M | 346.01%62.73M | 40.07%-4.55M | -231.51%-31.67M | -133.81%-26.3M | -111.45%-25.5M | -104.33%-7.59M | -84.20%24.08M |
| Basic earnings per share | 7,589.57%0.8613 | 732.42%0.5053 | 423.53%0.2145 | 346.03%0.1582 | 40.10%-0.0115 | -231.41%-0.0799 | -133.79%-0.0663 | -111.44%-0.0643 | -104.34%-0.0192 | -84.19%0.0608 |
| Diluted earnings per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | -- | -- | Deloitte Touche Tohmatsu CPA LLP | -- | -- | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.